Craciun, L.; Ignuta, F.; Rayudu, U.S.; Afra, M.; Rosca, O.; Vlad, A.; Aburel, O.; Velimirovici, D.E.
The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19. Biomedicines 2025, 13, 886.
https://doi.org/10.3390/biomedicines13040886
AMA Style
Craciun L, Ignuta F, Rayudu US, Afra M, Rosca O, Vlad A, Aburel O, Velimirovici DE.
The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19. Biomedicines. 2025; 13(4):886.
https://doi.org/10.3390/biomedicines13040886
Chicago/Turabian Style
Craciun, Lavinia, Flavia Ignuta, Uma Shailendri Rayudu, Maliha Afra, Ovidiu Rosca, Adrian Vlad, Oana Aburel, and Dana Emilia Velimirovici.
2025. "The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19" Biomedicines 13, no. 4: 886.
https://doi.org/10.3390/biomedicines13040886
APA Style
Craciun, L., Ignuta, F., Rayudu, U. S., Afra, M., Rosca, O., Vlad, A., Aburel, O., & Velimirovici, D. E.
(2025). The Role of Glycemic Control in Inflammation Markers and Clinical Outcomes in Type 2 Diabetes Patients with Severe COVID-19. Biomedicines, 13(4), 886.
https://doi.org/10.3390/biomedicines13040886
